The PE Ratio as of December 2024 (TTM) for Can-Fite BioPharma Ltd. (CANF) is -0.55

According to Can-Fite BioPharma Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.55. This represents a change of -63.22% compared to the average of -1.50 of the last 4 quarters.

Can-Fite BioPharma Ltd. (CANF) Historical PE Ratio (quarterly & annually)

How has CANF PE Ratio performed in the past?

The mean historical PE Ratio of Can-Fite BioPharma Ltd. over the last ten years is -3.27. The current -0.55 PE Ratio has changed 1.58% with respect to the historical average. Over the past ten years (40 quarters), CANF's PE Ratio was at its highest in in the December 2015 quarter at 31.29. The PE Ratio was at its lowest in in the September 2018 quarter at -39.45.

Can-Fite BioPharma Ltd. (CANF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Can-Fite BioPharma Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Can-Fite BioPharma Ltd. (CANF) Average PE Ratio

How has CANF PE Ratio performed in the past?

The current PE Ratio of Can-Fite BioPharma Ltd. (CANF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Can-Fite BioPharma Ltd. (CANF) PE Ratio vs. Peers

How is CANF’s PE Ratio compared to its peers?

Can-Fite BioPharma Ltd.’s PE Ratio is less than ImmuCell Corporation (-0.05), less than Compugen Ltd. (89.59), greater than Evogene Ltd. (-3.17), greater than CollPlant Biotechnologies Ltd. (-2.30), greater than Protalix BioTherapeutics, Inc. (-13.55), greater than Corvus Pharmaceuticals, Inc. (-5.75), greater than Aldeyra Therapeutics, Inc. (-6.32), less than Gamida Cell Ltd. (-0.23), greater than Checkpoint Therapeutics, Inc. (-3.38), greater than Candel Therapeutics, Inc. (-5.40), greater than BioRestorative Therapies, Inc. (-2.03), greater than XTL Biopharmaceuticals Ltd. (-103.40), less than Cingulate Inc. (-0.00), less than Adial Pharmaceuticals, Inc. (-0.47), greater than TransCode Therapeutics, Inc. (-3.46), less than Aditxt, Inc. (-0.00), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.80), less than Avenue Therapeutics, Inc. (-0.20), greater than BiondVax Pharmaceuticals Ltd. (-1931344.47), less than Oramed Pharmaceuticals Inc. (21.80), greater than MediWound Ltd. (-6.70), greater than BioLineRx Ltd. (-1.04),

Build a custom stock screener for Can-Fite BioPharma Ltd. (CANF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Can-Fite BioPharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Can-Fite BioPharma Ltd. (CANF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Can-Fite BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.